AlcaSynn Pharmaceuticals GmbH (APG) is a privately held drug development company, engaged in the preclinical and clinical development of morphinan opioids. The company holds material experience in the medicinal chemistry of morphinans. It has developed a broad portfolio of innovative drug candidates targeting a variety of different medicinal indications. The company focuses on the development of drugs with target molecules as opioid receptors. AlcaSynn distributes product licenses for the development and marketing of therapeutic medication, as well as services in the field of drug development. Its products are also used to treat rheumatoid arthritis, obstruction, intestinal itching, inflammatory skin diseases and stomach ulcers. AlcaSynn is a subsidiary of Sanochemia Pharmazeutika AG, Vienna. The company is headquartered in Innsbruck, Austria.

Street: 
Life Science Center
City: 
Innsbruck
Postcode: 
6020
Federal State : 
Austria
WebSite: 
www.alcasynn.com
Fax: 
43-512-28228344

Company Index Score

Current Index Score Historical Index Score
  • AlcaSynn Pharmaceuticals GmbH currently scores 50 % in the index.
  • AlcaSynn Pharmaceuticals GmbH is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • AlcaSynn Pharmaceuticals GmbH is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets